BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9450149)

  • 1. Oral "desensitization" of maculopapular exanthema from ciprofloxacin.
    Bircher AJ; Rutishauser M
    Allergy; 1997 Dec; 52(12):1246-8. PubMed ID: 9450149
    [No Abstract]   [Full Text] [Related]  

  • 2. Anaphylactic reaction to ciprofloxacin in a toddler: successful desensitization.
    Erdem G; Staat MA; Connelly BL; Assa'ad A
    Pediatr Infect Dis J; 1999 Jun; 18(6):563-4. PubMed ID: 10391195
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe Maculopapular Exanthema Induced by Regorafenib: Successful Desensitization and Adaptation of a Dosage Regimen.
    García-Gutiérrez I; Acevedo M; Tornero P; Matilla A; Márquez L; Sánchez-Herrero A; Prieto-García A
    J Investig Allergol Clin Immunol; 2019 Aug; 29(4):300-302. PubMed ID: 31478526
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful rifampin desensitization in a pediatric patient with latent tuberculosis.
    Logsdon S; Ramirez-Avila L; Castells M; Dioun A
    Pediatr Allergy Immunol; 2014 Jun; 25(4):404-5. PubMed ID: 24417546
    [No Abstract]   [Full Text] [Related]  

  • 5. [Delayed hypersensitivity to anti-tuberculosis drugs. Proposed practical management plan for exanthema: when to stop, which allergological investigations to perform, and how to restart treatment].
    Ingen-Housz-Oro S; Assier H; Gener G; Milpied B; Soria A; Bernier C; Descamps V; Tetart F; Staumont-Sallé D; Valeyrie-Allanore L; Valois A; Sassolas B; Bensaid B; Lebrun-Vignes B; Barbaud A;
    Ann Dermatol Venereol; 2019 Apr; 146(4):313-318. PubMed ID: 30904277
    [No Abstract]   [Full Text] [Related]  

  • 6. Desensitization to trimethoprim sulfamethoxazole in patients with acquired immune deficiency syndrome and Pneumocystis carinii pneumonia.
    White MV; Haddad ZH; Brunner E; Sainz C
    Ann Allergy; 1989 Mar; 62(3):177-9. PubMed ID: 2522290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin-induced vasculitis.
    Reaño M; Vives R; Rodríguez J; Daroca P; Canto G; Fernández J
    Allergy; 1997 May; 52(5):599-600. PubMed ID: 9201380
    [No Abstract]   [Full Text] [Related]  

  • 8. Desensitization to hydroxychloroquine: alternative interpretations.
    Sontheimer RD
    J Rheumatol; 2007 Feb; 34(2):253-5; discussion 255. PubMed ID: 17304648
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid desensitization with temozolomide in patients with delayed maculopapular rash.
    Alonso-Llamazares A; Vega-Castro A; Beitia-Mazuecos JM; Mateo-Borrega B; Cardenas-Contreras R
    J Investig Allergol Clin Immunol; 2012; 22(6):448-9. PubMed ID: 23101195
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypersensitivity reaction to darunavir and desensitization protocol.
    Marcos Bravo MC; Ocampo Hermida A; Martínez Vilela J; Pérez Rodríguez MT; Gavilán Montenegro MJ; Arenas Villarroel LJ; Miralles Alvarez C; Rodríguez Dasilva A; Martínez Vázquez C
    J Investig Allergol Clin Immunol; 2009; 19(3):250-1. PubMed ID: 19610279
    [No Abstract]   [Full Text] [Related]  

  • 11. Ciprofloxacin-induced cutaneous vasculitis.
    Lieu PK; Tok SC; Ismail NH; Chng HH
    Allergy; 1997 May; 52(5):593-4. PubMed ID: 9201375
    [No Abstract]   [Full Text] [Related]  

  • 12. [A severe case of infectious mononucleosis associated with ciprofloxacin and salazopyrin administration].
    Miftode E; Leca D; Luca V
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):652-5. PubMed ID: 20201247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin desensitization in a patient with cystic fibrosis.
    Lantner RR
    J Allergy Clin Immunol; 1995 Dec; 96(6 Pt 1):1001-2. PubMed ID: 8543732
    [No Abstract]   [Full Text] [Related]  

  • 14. Desensitization to hydroxychloroquine--experience of 4 patients.
    Mates M; Zevin S; Breuer GS; Navon P; Nesher G
    J Rheumatol; 2006 Apr; 33(4):814-6. PubMed ID: 16463436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization to co-trimoxazole in a patient with fixed drug eruption.
    Patriarca G; Schiavino D; Buonomo A; Aruanno A; Altomonte G; Nucera E
    J Investig Allergol Clin Immunol; 2008; 18(4):309-11. PubMed ID: 18714541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penicillin reactions. Desensitize or discontinue?
    Rocklin RE
    Hosp Pract (Off Ed); 1986 Jan; 21(1A):75-8, 81-3, 88-9. PubMed ID: 2935547
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus.
    Caumes E; Guermonprez G; Lecomte C; Katlama C; Bricaire F
    Arch Dermatol; 1997 Apr; 133(4):465-9. PubMed ID: 9126010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fixed drug eruption induced by ciprofloxacin].
    Maquirriain Górriz MT; Merino Muñoz F; Tres Belzunegui JC; Sangros González FJ
    Aten Primaria; 1998 May; 21(8):585-6. PubMed ID: 9670587
    [No Abstract]   [Full Text] [Related]  

  • 19. A case report of highly suspected ciprofloxacin-induced hepatotoxicity.
    Bhagirath KM
    Turk J Gastroenterol; 2008 Sep; 19(3):204-6. PubMed ID: 19115163
    [No Abstract]   [Full Text] [Related]  

  • 20. Amprenavir-induced maculopapular exanthem followed by desensitization in a patient with late-stage human immunodeficiency virus.
    Kohli-Pamnani A; Huynh P; Lobo F
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):620-3. PubMed ID: 16680935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.